Business Context and Reporting Period
This Form 8-K reports on the 2021 Annual Meeting of Stockholders held by Virios Therapeutics, Inc. on June 22, 2021. The filing details the results of shareholder votes regarding the election of directors and the ratification of the independent auditor. Note: The request metadata referenced "Dogwood Therapeutics, Inc.," but the filing text explicitly identifies the registrant as Virios Therapeutics, Inc.
Key Financial Metrics
This filing is a current report regarding corporate governance events and does not contain financial statements. Consequently, there is no data provided regarding revenue, profit, cash flow, margins, debt, or liquidity.
Material Changes
The filing reports the following material corporate actions approved by shareholders:
- Director Elections: Seven nominees were elected to the Board of Directors. All nominees received a majority of votes cast "For."
- Auditor Ratification: Shareholders ratified the appointment of Dixon Hughes Goodman, LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2021.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. It is strictly a disclosure of voting results.
Important Facts for Investors to Verify
- Shareholder Participation: Holders of 4,757,922 shares (57.11% of voting power) were present, establishing a quorum.
- Voting Results: All matters submitted to the vote were approved. Specifically, the auditor ratification received 4,746,392 votes "For" versus 3,931 "Against."
- Broker Non-Votes: There were 828,628 broker non-votes recorded for the election of directors, which did not affect the outcome as the votes "For" exceeded the votes "Withheld."
- Company Identity: Verify that the entity in question is Virios Therapeutics, Inc. (Ticker: VIRI), not Dogwood Therapeutics, Inc., as indicated in the filing header.